EphrinB2 drives perivascular invasion and proliferation of glioblastoma stem-like cells

eLife

Volumn 5, Issue JUNE2016, 2016, Pages

  Krusche, Benjamin ^a,b   Ottone, Cristina ^a,b   Clements, Melanie P ^a,b   Johnstone, Ewan R ^c,d   Goetsch, Katrin ^a,b   Lieven, Huang ^b,e   Mota, Silvia G ^f   Singh, Poonam ^g   Khadayate, Sanjay ^b   Ashraf, Azhaar ^a,b   Davies, Timothy ^a,b   Pollard, Steven M ^h   De Paola, Vincenzo ^b,e   Roncaroli, Federico ^g,i   Martinez Torrecuadrada, Jorge ^f   Bertone, Paul ^c,d   Parrinello, Simona ^a,b  

^a MRC CLINICAL SCIENCES CENTRE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d EUROPEAN BIOINFORMATICS INSTITUTE   (United Kingdom)

^e MEDICAL RESEARCH COUNCIL   (United Kingdom)

^f Centro Nacional de Investigations Oncológicas   (Spain)

^g IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^h UNIVERSITY OF EDINBURGH   (United Kingdom)

ⁱ UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPHRIN B2; EFNB2 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; BIOLUMINESCENCE; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL MIGRATION ASSAY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINESIS; FLOW CYTOMETRY; GENE SILENCING; GENE TARGETING; GENETIC ANALYSIS; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MOUSE; NEURAL STEM CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; TIME-LAPSE VIDEO MICROSCOPY; UPREGULATION; WESTERN BLOTTING; ANIMAL; CANCER STEM CELL; CELL MOTION; INTRAVITAL MICROSCOPY; METABOLISM; PATHOLOGY; PHYSIOLOGY; XENOGRAFT;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; EPHRIN-B2; GLIOBLASTOMA; HETEROGRAFTS; HUMANS; INTRAVITAL MICROSCOPY; MICE; NEOPLASTIC STEM CELLS;

EID: 84978869380     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.14845.001     Document Type: Article

References (82)

1. Abéngozar MA, de Frutos S, Ferreiro S, Soriano J, Perez-Martinez M, Olmeda D, Marenchino M, Cañamero M, Ortega S, Megias D, Rodriguez A, Martínez-Torrecuadrada JL. 2012. Blocking ephrinB2 with highly specific antibodies inhibits angiogenesis, lymphangiogenesis, and tumor growth. Blood 119:4565-4576. doi: 10.1182/blood-2011-09-380006
2. Anders S, Pyl PT, Huber W. 2015. HTSeq-a Python framework to work with high-throughput sequencing data. Bioinformatics 31:166-169. doi: 10.1093/bioinformatics/btu638
3. Astin JW, Batson J, Kadir S, Charlet J, Persad RA, Gillatt D, Oxley JD, Nobes CD. 2010. Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells. Nature Cell Biology 12:1194-1204. doi: 10.1038/ncb2122
4. Baker GJ, Yadav VN, Motsch S, Koschmann C, Calinescu AA, Mineharu Y, Camelo-Piragua SI, Orringer D, Bannykh S, Nichols WS, deCarvalho AC, Mikkelsen T, Castro MG, Lowenstein PR. 2014. Mechanisms of glioma formation: iterative perivascular glioma growth and invasion leads to tumor progression, VEGF-independent vascularization, and resistance to antiangiogenic therapy. Neoplasia 16:543-561. doi: 10.1016/j.neo.2014.06.003
5. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN. 2006. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444:756-760. doi: 10.1038/nature05236
6. Bhat KP, Balasubramaniyan V, Vaillant B, Ezhilarasan R, Hummelink K, Hollingsworth F, Wani K, Heathcock L, James JD, Goodman LD, Conroy S, Long L, Lelic N, Wang S, Gumin J, Raj D, Kodama Y, Raghunathan A, Olar A, Joshi K, et al. 2013. Mesenchymal differentiation mediated by NF-kB promotes radiation resistance in glioblastoma. Cancer Cell 24:331-346. doi: 10.1016/j.ccr.2013.08.001
7. Binda E, Visioli A, Giani F, Lamorte G, Copetti M, Pitter KL, Huse JT, Cajola L, Zanetti N, DiMeco F, De Filippis L, Mangiola A, Maira G, Anile C, De Bonis P, Reynolds BA, Pasquale EB, Vescovi AL. 2012. The EphA2 receptor drives self-renewal and tumorigenicity in stem-like tumor-propagating cells from human glioblastomas. Cancer Cell 22:765-780. doi: 10.1016/j.ccr.2012.11.005
8. Blouw B, Song H, Tihan T, Bosze J, Ferrara N, Gerber HP, Johnson RS, Bergers G. 2003. The hypoxic response of tumors is dependent on their microenvironment. Cancer Cell 4:133-146. doi: 10.1016/S1535-6108(03)00194-6
9. Bochenek ML, Dickinson S, Astin JW, Adams RH, Nobes CD. 2010. Ephrin-B2 regulates endothelial cell morphology and motility independently of Eph-receptor binding. Journal of Cell Science 123:1235-1246. doi: 10.1242/jcs.061903
10. Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, Hamner B, Oh EY, Gaber MW, Finklestein D, Allen M, Frank A, Bayazitov IT, Zakharenko SS, Gajjar A, Davidoff A, Gilbertson RJ. 2007. A perivascular niche for brain tumor stem cells. Cancer Cell 11:69-82. doi: 10.1016/j.ccr.2006.11.020
11. Carén H, Stricker SH, Bulstrode H, Gagrica S, Johnstone E, Bartlett TE, Feber A, Wilson G, Teschendorff AE, Bertone P, Beck S, Pollard SM. 2015. Glioblastoma Stem Cells Respond to Differentiation Cues but Fail to Undergo Commitment and Terminal Cell-Cycle Arrest. Stem Cell Reports 5. doi: 10.1016/j.stemcr.2015.09.014
12. Carro MS, Lim WK, Alvarez MJ, Bollo RJ, Zhao X, Snyder EY, Sulman EP, Anne SL, Doetsch F, Colman H, Lasorella A, Aldape K, Califano A, Iavarone A. 2010. The transcriptional network for mesenchymal transformation of brain tumours. Nature 463:318-325. doi: 10.1038/nature08712
13. Cayuso J, Xu Q, Wilkinson DG. 2015. Mechanisms of boundary formation by Eph receptor and ephrin signaling. Developmental Biology 401. doi: 10.1016/j.ydbio.2014.11.013
14. Charles N, Holland EC. 2010. The perivascular niche microenvironment in brain tumor progression. Cell Cycle 9: 3012-3021. doi: 10.4161/cc.9.15.12335
15. Chen J, Li Y, Yu TS, McKay RM, Burns DK, Kernie SG, Parada LF. 2012. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 488:522-526. doi: 10.1038/nature11287
16. Chen J, McKay RM, Parada LF. 2012. Malignant glioma: lessons from genomics, mouse models, and stem cells. Cell 149:36-47. doi: 10.1016/j.cell.2012.03.009
17. Cheng L, Wu Q, Guryanova OA, Huang Z, Huang Q, Rich JN, Bao S. 2011. Elevated invasive potential of glioblastoma stem cells. Biochemical and Biophysical Research Communications 406:643-648. doi: 10.1016/j.bbrc.2011.02.123
18. Cortina C, Palomo-Ponce S, Iglesias M, Fernández-Masip JL, Vivancos A, Whissell G, Humà M, Peiró N, Gallego L, Jonkheer S, Davy A, Lloreta J, Sancho E, Batlle E. 2007. EphB-ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells. Nature Genetics 39:1376-1383. doi: 10.1038/ng.2007.11
19. Cremona CA, Lloyd AC. 2009. Loss of anchorage in checkpoint-deficient cells increases genomic instability and promotes oncogenic transformation. Journal of Cell Science 122:3272-3281. doi: 10.1242/jcs.047126
20. Cuddapah VA, Robel S, Watkins S, Sontheimer H. 2014. A neurocentric perspective on glioma invasion. Nature Reviews. Neuroscience 15:455-465. doi: 10.1038/nrn3765
21. Cunningham F, Amode MR, Barrell D, Beal K, Billis K, Brent S, Carvalho-Silva D, Clapham P, Coates G, Fitzgerald S, Gil L, Girón CG, Gordon L, Hourlier T, Hunt SE, Janacek SH, Johnson N, Juettemann T, Kahari AK, Keenan S, et al. 2015. Ensembl 2015. Nucleic Acids Research 43:D662-669. doi: 10.1093/nar/gku1010
22. Daar IO. 2012. Non-SH2/PDZ reverse signaling by ephrins. Seminars in Cell & Developmental Biology 23:65-74. doi: 10.1016/j.semcdb.2011.10.012
23. Day BW, Stringer BW, Al-Ejeh F, Ting MJ, Wilson J, Ensbey KS, Jamieson PR, Bruce ZC, Lim YC, Offenhauser C, Charmsaz S, Cooper LT, Ellacott JK, Harding A, Leveque L, Inglis P, Allan S, Walker DG, Lackmann M, Osborne G, et al. 2013. EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiforme. Cancer Cell 23:238-248. doi: 10.1016/j.ccr.2013.01.007
24. Day BW, Stringer BW, Boyd AW. 2014. Eph receptors as therapeutic targets in glioblastoma. British Journal of Cancer 111:1255-1261. doi: 10.1038/bjc.2014.73
25. Desgrosellier JS, Barnes LA, Shields DJ, Huang M, Lau SK, Prévost N, Tarin D, Shattil SJ, Cheresh DA. 2009. An integrin alpha(v)beta(3)-c-Src oncogenic unit promotes anchorage-independence and tumor progression. Nature Medicine 15:1163-1169. doi: 10.1038/nm.2009
26. Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. 2013. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29:15-21. doi: 10.1093/bioinformatics/bts635
27. Donnem T, Hu J, Ferguson M, Adighibe O, Snell C, Harris AL, Gatter KC, Pezzella F. 2013. Vessel co-option in primary human tumors and metastases: an obstacle to effective anti-angiogenic treatment? Cancer Medicine 2: 427-436. doi: 10.1002/cam4.105
28. Engstrom PG, Tommei D, Stricker SH, Ender C, Pollard SM, Bertone P. 2012. Digital transcriptome profiling of normal and glioblastoma-derived neural stem cells identifies genes associated with patient survival. Genome Medicine 4. doi: 10.1186/gm377
29. Farin A, Suzuki SO, Weiker M, Goldman JE, Bruce JN, Canoll P. 2006. Transplanted glioma cells migrate and proliferate on host brain vasculature: a dynamic analysis. Glia 53:799-808. doi: 10.1002/glia.20334
30. Foo SS, Turner CJ, Adams S, Compagni A, Aubyn D, Kogata N, Lindblom P, Shani M, Zicha D, Adams RH. 2006. Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly. Cell 124:161-173. doi: 10.1016/j.cell.2005.10.034
31. Freedman VH, Shin SI. 1974. Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. Cell 3:355-359. doi: 10.1016/0092-8674(74)90050-6
32. Gale NW, Baluk P, Pan L, Kwan M, Holash J, DeChiara TM, McDonald DM, Yancopoulos GD. 2001. Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells. Developmental Biology 230:151-160. doi: 10.1006/dbio.2000.0112
33. Godar S, Ince TA, Bell GW, Feldser D, Donaher JL, Bergh J, Liu A, Miu K, Watnick RS, Reinhardt F, McAllister SS, Jacks T, Weinberg RA. 2008. Growth-inhibitory and tumor-suppressive functions of p53 depend on its repression of CD44 expression. Cell 134:62-73. doi: 10.1016/j.cell.2008.06.006
34. Gritsenko PG, Ilina O, Friedl P. 2012. Interstitial guidance of cancer invasion. The Journal of Pathology 226:185-199. doi: 10.1002/path.3031
35. Gursel DB, Shin BJ, Burkhardt JK, Kesavabhotla K, Schlaff CD, Boockvar JA. 2011. Glioblastoma stem-like cells-biology and therapeutic implications. Cancers 3:2655-2666. doi: 10.3390/cancers3022655
36. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA. 1999. Creation of human tumour cells with defined genetic elements. Nature 400:464-468. doi: 10.1038/22780
37. van den Heuvel S, Harlow E. 1993. Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262: 2050-2054. doi: 10.1126/science.8266103
38. Holtmaat A, Bonhoeffer T, Chow DK, Chuckowree J, De Paola V, Hofer SB, Hubener M, Keck T, Knott G, Lee WC, Mostany R, Mrsic-Flogel TD, Nedivi E, Portera-Cailliau C, Svoboda K, Trachtenberg JT, Wilbrecht L. 2009. Long-term, high-resolution imaging in the mouse neocortex through a chronic cranial window. Nature Protocols 4:1128-1144. doi: 10.1038/nprot.2009.89
39. Huszthy PC, Daphu I, Niclou SP, Stieber D, Nigro JM, Sakariassen PØ, Miletic H, Thorsen F, Bjerkvig R. 2012. In vivo models of primary brain tumors: pitfalls and perspectives. Neuro-Oncology 14:979-993. doi: 10.1093/neuonc/nos135
40. Jordan SN, Canman JC. 2012. Rho GTPases in animal cell cytokinesis: an occupation by the one percent. Cytoskeleton 69:919-930. doi: 10.1002/cm.21071
41. Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL. 2013. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biology 14:R36. doi: 10.1186/gb-2013-14-4-r36
42. Kleihues P, Cavenee W. 2000. Pathology and Genetics of Tumours of the Nervous System. Lyon, France: IARC Press.
43. Kokovay E, Goderie S, Wang Y, Lotz S, Lin G, Sun Y, Roysam B, Shen Q, Temple S. 2010. Adult SVZ lineage cells home to and leave the vascular niche via differential responses to SDF1/CXCR4 signaling. Cell Stem Cell 7:163-173. doi: 10.1016/j.stem.2010.05.019
44. Kullander K, Klein R. 2002. Mechanisms and functions of Eph and ephrin signalling. Nature Reviews. Molecular Cell Biology 3:475-486. doi: 10.1038/nrm856
45. Lamszus K, Kunkel P, Westphal M. 2003. Invasion as limitation to anti-angiogenic glioma therapy. Acta Neurochirurgica. Supplement 88:169-177. doi: 10.1007/978-3-7091-6090-9_23
46. Lois C, Hong EJ, Pease S, Brown EJ, Baltimore D. 2002. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295:868-872. doi: 10.1126/science.1067081
47. Love MI, Huber W, Anders S. 2014. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biology 15. doi: 10.1186/s13059-014-0550-8
48. Luo W, Friedman MS, Shedden K, Hankenson KD, Woolf PJ. 2009. GAGE: generally applicable gene set enrichment for pathway analysis. BMC Bioinformatics 10:161. doi: 10.1186/1471-2105-10-161
49. Mao P, Joshi K, Li J, Kim SH, Li P, Santana-Santos L, Luthra S, Chandran UR, Benos PV, Smith L, Wang M, Hu B, Cheng SY, Sobol RW, Nakano I. 2013. Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3. Proceedings of the National Academy of Sciences of the United States of America 110:8644-8649. doi: 10.1073/pnas.1221478110
50. Nagano N, Sasaki H, Aoyagi M, Hirakawa K. 1993. Invasion of experimental rat brain tumor: early morphological changes following microinjection of C6 glioma cells. Acta Neuropathologica 86:117-125. doi: 10.1007/BF00334878
51. Nakada M, Anderson EM, Demuth T, Nakada S, Reavie LB, Drake KL, Hoelzinger DB, Berens ME. 2010. The phosphorylation of ephrin-B2 ligand promotes glioma cell migration and invasion. International Journal of Cancer 126:1155-1165. doi: 10.1002/ijc.24849
52. Nakada M, Hayashi Y, Hamada J. 2011. Role of Eph/ephrin tyrosine kinase in malignant glioma. Neuro-Oncology 13:1163-1170. doi: 10.1093/neuonc/nor102
53. Cancer Genome Atlas Research Network. 2008. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455:1061-1068. doi: 10.1038/nature07385
54. Ottone C, Krusche B, Whitby A, Clements M, Quadrato G, Pitulescu ME, Adams RH, Parrinello S. 2014. Direct cell-cell contact with the vascular niche maintains quiescent neural stem cells. Nature Cell Biology 16:1045-1056. doi: 10.1038/ncb3045
55. Ozawa T, James CD. 2010. Establishing Intracranial Brain Tumor Xenografts with Subsequent Analysis of Tumor Growth and Response to Therapy Using Bioluminescence Imaging. Journal of visualized experiments: JoVe. doi: 10.3791/1986
56. Ozawa T, Riester M, Cheng YK, Huse JT, Squatrito M, Helmy K, Charles N, Michor F, Holland EC. 2014. Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma. Cancer Cell 26:288-300. doi: 10.1016/j.ccr.2014.06.005
57. Pasquale EB. 2010. Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nature Reviews. Cancer 10:165-180. doi: 10.1038/nrc2806
58. Pfaff D, Héroult M, Riedel M, Reiss Y, Kirmse R, Ludwig T, Korff T, Hecker M, Augustin HG. 2008. Involvement of endothelial ephrin-B2 in adhesion and transmigration of EphB-receptor-expressing monocytes. Journal of Cell Science 121:3842-3850. doi: 10.1242/jcs.030627
59. Pollard SM, Yoshikawa K, Clarke ID, Danovi D, Stricker S, Russell R, Bayani J, Head R, Lee M, Bernstein M, Squire JA, Smith A, Dirks P. 2009. Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell 4:568-580. doi: 10.1016/j.stem.2009.03.014
60. Qiu RG, Chen J, McCormick F, Symons M. 1995. A role for Rho in Ras transformation. Proceedings of the National Academy of Sciences of the United States of America 92:11781-11785. doi: 10.1073/pnas.92.25.11781
61. Rasper M, Schafer A, Piontek G, Teufel J, Brockhoff G, Ringel F, Heindl S, Zimmer C, Schlegel J. 2010. Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity. Neuro-Oncology 12:1024-1033. doi: 10.1093/neuonc/noq070
62. Ridley AJ, Hall A. 1992. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70:389-399. doi: 10.1016/0092-8674(92)90163-7
63. Sadahiro H, Yoshikawa K, Ideguchi M, Kajiwara K, Ishii A, Ikeda E, Owada Y, Yasumoto Y, Suzuki M. 2014. Pathological features of highly invasive glioma stem cells in a mouse xenograft model. Brain Tumor Pathology 31:77-84. doi: 10.1007/s10014-013-0149-x
64. Sawamiphak S, Seidel S, Essmann CL, Wilkinson GA, Pitulescu ME, Acker T, Acker-Palmer A. 2010. Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis. Nature 465:487-491. doi: 10.1038/nature08995
65. Scherer HJ. 1938. Structural Development in gliomas. American Journal of Cancer 34:333-351.
66. Sonoda Y, Ozawa T, Hirose Y, Aldape KD, McMahon M, Berger MS, Pieper RO. 2001. Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma. Cancer Research 61:4956-4960.
67. Montana V, Sontheimer H. 2011. Bradykinin promotes the chemotactic invasion of primary brain tumors. The Journal of Neuroscience 31:4858-4867. doi: 10.1523/JNEUROSCI.3825-10.2011
68. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America 102:15545-15550. doi: 10.1073/pnas.0506580102
69. Tanaka M, Kamo T, Ota S, Sugimura H. 2003. Association of Dishevelled with Eph tyrosine kinase receptor and ephrin mediates cell repulsion. The EMBO Journal 22:847-858. doi: 10.1093/emboj/cdg088
70. Thullberg M, Gad A, Le Guyader S, Stromblad S. 2007. Oncogenic H-Ras V12 promotes anchorage-independent cytokinesis in human fibroblasts. Proceedings of the National Academy of Sciences of the United States of America 104:20338-20343. doi: 10.1073/pnas.0706609105
71. Tu Y, He S, Fu J, Li G, Xu R, Lu H, Deng J. 2012. Expression of EphrinB2 and EphB4 in glioma tissues correlated to the progression of glioma and the prognosis of glioblastoma patients. Clinical & Translational Oncology 14: 214-220. doi: 10.1007/s12094-012-0786-2
72. Vehlow A, Cordes N. 2013. Invasion as target for therapy of glioblastoma multiforme. Biochimica Et Biophysica Acta 1836:236-244. doi: 10.1016/j.bbcan.2013.07.001
73. Venere M, Fine HA, Dirks PB, Rich JN. 2011. Cancer stem cells in gliomas: identifying and understanding the apex cell in cancer’s hierarchy. Glia 59:1148-1154. doi: 10.1002/glia.21185
74. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, Alexe G, Lawrence M, O’Kelly M, Tamayo P, Weir BA, Gabriel S, Winckler W, Gupta S, Jakkula L, Feiler HS, et al. 2010. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17:98-110. doi: 10.1016/j.ccr.2009.12.020
75. Wang Y, Nakayama M, Pitulescu ME, Schmidt TS, Bochenek ML, Sakakibara A, Adams S, Davy A, Deutsch U, Luthi U, Barberis A, Benjamin LE, Makinen T, Nobes CD, Adams RH. 2010. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature 465:483-486. doi: 10.1038/nature09002
76. Wang Y, Kim E, Wang X, Novitch BG, Yoshikawa K, Chang LS, Zhu Y. 2012. ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities. Cell 150:816-830. doi: 10.1016/j.cell.2012.06.034
77. Watkins S, Robel S, Kimbrough IF, Robert SM, Ellis-Davies G, Sontheimer H. 2014. Disruption of astrocyte-vascular coupling and the blood-brain barrier by invading glioma cells. Nature Communications 5. doi: 10.1038/ncomms5196
78. Weathers SP, Gilbert MR. 2014. Advances in treating glioblastoma. F1000prime Reports 6. doi: 10.12703/P6-46
79. Winkler F, Kienast Y, Fuhrmann M, Von Baumgarten L, Burgold S, Mitteregger G, Kretzschmar H, Herms J. 2009. Imaging glioma cell invasion in vivo reveals mechanisms of dissemination and peritumoral angiogenesis. Glia 57:1306-1315. doi: 10.1002/glia.20850
80. Zagzag D, Esencay M, Mendez O, Yee H, Smirnova I, Huang Y, Chiriboga L, Lukyanov E, Liu M, Newcomb EW. 2008. Hypoxia-and vascular endothelial growth factor-induced stromal cell-derived factor-1alpha/CXCR4 expression in glioblastomas: one plausible explanation of Scherer’s structures. The American Journal of Pathology 173:545-560. doi: 10.2353/ajpath.2008.071197
81. Zhang Y, Chen K, Sloan SA, Bennett ML, Scholze AR, O’Keeffe S, Phatnani HP, Guarnieri P, Caneda C, Ruderisch N, Deng S, Liddelow SA, Zhang C, Daneman R, Maniatis T, Barres BA, Wu JQ. 2014. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. The Journal of Neuroscience 34:11929-11947. doi: 10.1523/JNEUROSCI.1860-14.2014
82. Zhu Y, Romero MI, Ghosh P, Ye Z, Charnay P, Rushing EJ, Marth JD, Parada LF. 2001. Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain. Genes & Development 15:859-876. doi: 10.1101/gad.862101